Komori
Nihon Nohyaku (4997) · FactAdvanced

Improved Quarterly Results Through Revenue and Profit Growth

First written in FY2019-Q1. 13 of 25 entries say "Advanced", first in FY2019-Q3. Latest entry: 2026-08-06.

25entries
9years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseReframedFY2020-Q1 – FY2021-Q1AdvancedFY2022-Q3 – FY2023OtherFY2024-Q2 – FY2025-H12018: 120182019: 320192020: 320202021: 420212022: 420222023: 420232024: 220242025: 220252026: 22026
Same theme, other companies
Performance and profitability trends, including growth and changes in revenue and profitA theme 620 companies write about · 47 as a headwind · 763 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 126 companies compared. The sentences above are computed from all 126.Comparing 200 of the theme's 899 threads.
Full recordFilings, disclosures and news, newest first
  1. 2026-08-06AdvancedEarnings

    「In addition to the effect of higher revenue, improved profitability contributed to operating income of ¥4,751 million, up ¥1,209 million, or 34.1%, year on year; ordinary income of ¥5,229 million, up ¥1,804 million, or 52.7%; and net income attributable to owners of the parent of ¥3,729 million, up ¥1,019 million, or 37.6%.」

    In the first quarter, improved profitability in addition to higher revenue contributed to increases in operating income, ordinary income, and net income attributable to owners of the parent compared with the same period of the previous fiscal year.
  2. FY2026AdvancedAnnual report

    「Revenue for the current consolidated fiscal year was ¥111,822 million, up ¥11,855 million, or 11.9%, year on year. In terms of earnings, operating income was ¥10,878 million, up ¥2,301 million, or 26.8%, and ordinary income was ¥10,527 million, up ¥3,440 million, or 48.6%.」

    Against a backdrop of increased agrochemicals sales in Japan, North America and Europe, revenue reached a record high, while operating income and ordinary income also exceeded the previous year's levels.
  3. FY2026-H1AdvancedAnnual report

    「Revenue for the current six-month consolidated period was ¥47,710 million, up ¥8,581 million, or 21.9%, year on year, mainly because agrochemicals sales increased in each region. In terms of earnings, operating income was ¥4,687 million, up ¥3,657 million, or 355.3%, year on year; ordinary income was ¥4,661 million, up ¥4,142 million, or 798.0%; and interim net income attributable to owners of the parent was ¥3,372 million, up ¥2,751 million, or 443.2%.」

    Against a backdrop of increased agrochemicals sales in each region, revenue rose 21.9%, operating income 355.3%, ordinary income 798.0% and interim net income attributable to owners of the parent 443.2%.
  4. FY2025ReframedAnnual report

    「Revenue for the current consolidated fiscal year was ¥99,966 million, down ¥3,066 million, or 3.0%, year on year. In terms of earnings, operating income was ¥8,576 million, up ¥1,138 million, or 15.3%; ordinary income was ¥7,086 million, up ¥1,154 million, or 19.5%; and net income attributable to owners of the parent was ¥2,356 million, down ¥2,421 million, or 50.7%.」

    The earnings profile has shifted from the previous trend of higher revenue and higher profits: revenue declined, while operating income and ordinary income increased, and final profit declined substantially due to impairment losses and other factors.
  5. FY2025-H1Continued lower sales and lower profitAnnual report

    「Revenue for the cumulative six-month period of the current consolidated fiscal year was ¥39,129 million, down ¥1,541 million, or 3.8%, year on year, mainly because sales of agrochemicals to industry peers in India declined in the core agrochemicals business. In terms of earnings, operating income was ¥1,029 million, down ¥146 million, or 12.5%, year on year; ordinary income was ¥519 million, down ¥432 million, or 45.4%; and interim net income attributable to owners of the parent was ¥620 million, down ¥75 million, or 10.8%.」

    The declining revenue and profits seen through the previous quarter continued during the current six-month consolidated period, with revenue, operating income, ordinary income and interim net income attributable to owners of the parent all below the previous year's levels.
  6. FY2024-Q3Continued lower sales and lower profitAnnual report

    「Revenue for the cumulative third quarter of the current consolidated fiscal year was ¥63,290 million, down ¥2,715 million, or 4.1%, year on year, as the core agrochemicals business struggled in both Japan and overseas due to unfavorable weather and the effects of distribution inventories from previous years. In terms of earnings, operating income was ¥2,555 million, down ¥2,563 million, or 50.1%, year on year; ordinary income was ¥1,782 million, down ¥2,843 million, or 61.5%; and quarterly net income attributable to owners of the parent was ¥1,460 million, down ¥1,583 million, or 52.0%.」

    Revenue and profits declined again from the previous quarter, with revenue down 4.1%, operating income down 50.1%, ordinary income down 61.5% and quarterly net income attributable to owners of the parent down 52.0%.
  7. FY2024-Q2Continued lower sales and lower profitAnnual report

    「Revenue for the cumulative second quarter of the current consolidated fiscal year was ¥40,670 million, down ¥2,496 million, or 5.8%, year on year, as the core agrochemicals business struggled in both Japan and overseas due to unfavorable weather and the effects of distribution inventories from previous years. In terms of earnings, operating income was ¥1,176 million, down ¥1,854 million, or 61.2%, year on year; ordinary income was ¥951 million, down ¥2,246 million, or 70.3%; and quarterly net income attributable to owners of the parent was ¥695 million, down ¥1,887 million, or 73.1%.」

    As in the previous quarter, revenue and profits declined against a backdrop of unfavorable weather and the effects of distribution inventories. Revenue, operating income, ordinary income and quarterly net income attributable to owners of the parent all fell below the previous year's levels.
  8. FY2024-Q1ReframedAnnual report

    「Revenue for the cumulative first quarter of the current consolidated fiscal year was ¥22,183 million, down ¥1,832 million, or 7.6%, year on year, as the core agrochemicals business struggled in both Japan and overseas due to unfavorable weather and the effects of distribution inventories from previous years. In terms of earnings, operating income was ¥1,385 million, down ¥1,395 million, or 50.2%, year on year; ordinary income was ¥1,326 million, down ¥1,759 million, or 57.0%; and quarterly net income attributable to owners of the parent was ¥1,038 million, down ¥1,471 million, or 58.6%.」

    Following higher revenue and higher profits in the previous year, the first quarter turned to declines of 7.6% in revenue, 50.2% in operating income, 57.0% in ordinary income and 58.6% in quarterly net income attributable to owners of the parent.
  9. FY2023AdvancedAnnual report

    「Revenue for the current consolidated fiscal year was ¥102,090 million, up ¥21,979 million, or 27.4%, year on year. In terms of earnings, operating income was ¥8,739 million, up ¥2,976 million, or 51.6%; ordinary income was ¥7,779 million, up ¥2,114 million, or 37.3%; and net income attributable to owners of the parent was ¥4,488 million, up ¥82 million, or 1.9%.」

    Full-year revenue, operating income, ordinary income and net income attributable to owners of the parent are disclosed, with revenue, operating income and ordinary income increasing substantially.
  10. FY2023-Q3AdvancedAnnual report

    「Revenue for the cumulative third quarter of the current consolidated fiscal year was ¥66,006 million, up ¥15,185 million, or 29.9%, year on year, mainly because the core agrochemicals business performed well overseas. In terms of earnings, operating income was ¥5,119 million, up ¥2,217 million, or 76.4%, year on year; ordinary income was ¥4,626 million, up ¥1,384 million, or 42.7%; and quarterly net income attributable to owners of the parent was ¥3,043 million, up ¥539 million, or 21.6%.」

    All of revenue, operating income, ordinary income and quarterly net income attributable to owners of the parent exceeded the previous year's levels, supported by strong performance in the overseas agrochemicals business, and higher revenue and higher profits continued to advance.
  11. FY2023-Q2AdvancedAnnual report

    「Revenue for the cumulative second quarter of the current consolidated fiscal year was ¥43,167 million, up ¥11,687 million, or 37.1%, year on year, as the core agrochemicals business performed well overseas. In terms of earnings, operating income was ¥3,030 million, up ¥1,585 million, or 109.7%, year on year; ordinary income was ¥3,197 million, up ¥1,629 million, or 103.9%; and quarterly net income attributable to owners of the parent was ¥2,582 million, up ¥1,034 million, or 66.8%.」

    Revenue, operating income, ordinary income and quarterly net income attributable to owners of the parent exceeded the previous year's levels, supported by strong performance in the overseas agrochemicals business, and higher revenue and higher profits continued to advance.
  12. FY2023-Q1AdvancedAnnual report

    「Revenue for the cumulative first quarter of the current consolidated fiscal year was ¥24,015 million, up ¥7,509 million, or 45.5%, year on year, as the core agrochemicals business performed well overseas. In terms of earnings, operating income was ¥2,781 million, up ¥1,130 million, or 68.5%, year on year; ordinary income was ¥3,085 million, up ¥1,318 million, or 74.6%; and quarterly net income attributable to owners of the parent was ¥2,509 million, up ¥872 million, or 53.3%.」

    Revenue, operating income, ordinary income and quarterly net income attributable to owners of the parent exceeded the previous year's levels, supported by strong performance in the overseas agrochemicals business.
  13. FY2022AdvancedAnnual report

    「Revenue for the current consolidated fiscal year was ¥81,910 million, up ¥10,385 million, or 14.5%, year on year. In terms of earnings, operating income was ¥6,642 million, down ¥339 million, or 4.9%; ordinary income was ¥5,768 million, up ¥46 million, or 0.8%; and net income attributable to owners of the parent was ¥4,502 million, up ¥157 million, or 3.6%.」

    Full-year revenue, ordinary income and net income attributable to owners of the parent exceeded the previous year's levels, while operating income declined.
  14. FY2022-Q3AdvancedAnnual report

    「Revenue for the cumulative third quarter of the current consolidated fiscal year was ¥51,283 million, up ¥9,478 million, or 22.7%, year on year, mainly because the core agrochemicals business performed well overseas. In terms of earnings, operating income was ¥3,193 million, up ¥1,255 million, or 64.8%, year on year; ordinary income was ¥3,246 million, up ¥1,971 million, or 154.7%; and quarterly net income attributable to owners of the parent was ¥2,514 million, up ¥1,121 million, or 80.5%.」

    Supported by strong performance in the overseas agrochemicals business, revenue, operating income, ordinary income and quarterly net income attributable to owners of the parent all exceeded the previous year's levels, with performance shifting from the divergent trends by line item seen through the previous quarter toward overall higher revenue and higher profits.
  15. FY2022-Q2ReframedAnnual report

    「Revenue for the cumulative second quarter of the current consolidated fiscal year was ¥31,938 million, up ¥2,897 million, or 10.0%, year on year, mainly because the core agrochemicals business performed well overseas. In terms of earnings, operating income was ¥1,558 million, down ¥13 million, or 0.8%, year on year; ordinary income was ¥1,510 million, up ¥449 million, or 42.4%; and quarterly net income attributable to owners of the parent was ¥1,529 million, up ¥308 million, or 25.3%.」

    Revenue, ordinary income and quarterly net income attributable to owners of the parent increased, supported by strong overseas performance in the agrochemicals business, while operating income declined 0.8%, resulting in performance trends that diverged by line item.
  16. FY2022-Q1AdvancedAnnual report

    「Revenue for the cumulative first quarter of the current consolidated fiscal year was ¥16,547 million, up ¥2,483 million, or 17.7%, year on year, as the core agrochemicals business performed well both in Japan and overseas. In terms of earnings, operating income was ¥1,670 million, up ¥420 million, or 33.6%, year on year; ordinary income was ¥1,772 million, up ¥1,047 million, or 144.5%; and quarterly net income attributable to owners of the parent was ¥1,642 million, up ¥885 million, or 117.0%.」

    Revenue, operating income, ordinary income and quarterly net income attributable to owners of the parent exceeded the previous year's levels, supported by strong performance in the agrochemicals business in Japan and overseas.
  17. FY2021AdvancedAnnual report

    「Revenue for the current consolidated fiscal year was ¥71,525 million. In terms of earnings, operating income was ¥6,981 million, ordinary income was ¥5,722 million, and net income attributable to owners of the parent was ¥4,344 million.」

    Although no year-on-year comparison is provided because the fiscal year-end was changed, full-year revenue of ¥71,525 million, operating income of ¥6,981 million, ordinary income of ¥5,722 million and net income attributable to owners of the parent of ¥4,344 million are disclosed. Operating income exceeded the ¥4,700 million target in the EGG2021 plan.
  18. FY2021-Q3RestatedAnnual report

    「Revenue for the cumulative third quarter of the current consolidated fiscal year was ¥41,804 million. In terms of earnings, operating income was ¥1,937 million, ordinary income was ¥1,274 million, and quarterly net income attributable to owners of the parent was ¥1,393 million.」

    Because the fiscal year-end was changed, no year-on-year comparison with the same cumulative third quarter is provided. Revenue, operating income, ordinary income and quarterly profit attributable to owners of the parent are disclosed as absolute figures for the cumulative third quarter.
  19. FY2021-Q2RestatedAnnual report

    「Revenue for the cumulative second quarter of the current consolidated fiscal year was ¥29,041 million. In terms of earnings, operating income was ¥1,571 million, ordinary income was ¥1,060 million, and quarterly net income attributable to owners of the parent was ¥1,220 million.」

    Because the fiscal year-end was changed, no year-on-year comparison with the same cumulative second quarter is provided. Revenue, operating income, ordinary income and quarterly profit attributable to owners of the parent are disclosed as absolute figures for the cumulative second quarter.
  20. FY2021-Q1ReframedAnnual report

    「Revenue for the cumulative first quarter of the current consolidated fiscal year was ¥14,063 million. In terms of earnings, operating income was ¥1,250 million, ordinary income was ¥724 million, and quarterly net income attributable to owners of the parent was ¥756 million.」

    Because the fiscal year-end was changed, no year-on-year comparison with the same quarter of the previous year is provided. Revenue, operating income, ordinary income and profit attributable to owners of the parent are disclosed as absolute figures for the first quarter.
  21. FY2020-Q3ReframedAnnual report

    「Net sales for the cumulative first-quarter period under review increased by ¥74 million, or 0.6%, year on year, to ¥11,683 million. In terms of profit, the operating loss narrowed by ¥43 million year on year to ¥192 million, while the ordinary loss widened by ¥195 million to ¥345 million, and the quarterly net loss attributable to owners of the parent narrowed by ¥31 million to ¥170 million.」

    Revenue increased 0.6%, and operating loss and quarterly net loss attributable to owners of the parent improved, while ordinary loss widened. The explanation has shifted from the consistent trend of higher revenue and higher profits seen through the previous period to one in which trends diverge by line item.
  22. FY2020-Q1ReframedAnnual report

    「The Group's net sales for the cumulative third-quarter period under review decreased by ¥57 million, or 0.1%, year on year, to ¥48,223 million. In terms of profit, operating income decreased by ¥440 million, or 11.1%, to ¥3,534 million, and ordinary income decreased by ¥445 million, or 11.4%, to ¥3,460 million. Quarterly net income attributable to owners of the parent increased by ¥119 million, or 5.0%, to ¥2,526 million, partly because a gain on the sale of shares of the parent company was recorded as an extraordinary gain.」

    The previous trend of higher sales and profit changed to a 0.1% decline in net sales, an 11.1% decline in operating income and an 11.4% decline in ordinary income. Meanwhile, quarterly net income attributable to owners of the parent increased by 5.0% due to the recognition of a gain on the sale of shares of the parent company.
  23. FY2019-Q4AdvancedAnnual report

    「Net sales for the cumulative second-quarter period under review increased by ¥231 million, or 0.6%, year on year, to ¥37,186 million. Profit also increased, with operating income rising by ¥360 million, or 9.6%, to ¥4,092 million, ordinary income rising by ¥127 million, or 3.2%, to ¥4,082 million, and quarterly net income attributable to owners of the parent rising by ¥455 million, or 18.0%, to ¥2,981 million, owing partly to higher know-how and technology fee income.」

    The cumulative second-quarter period saw higher sales, while operating income, ordinary income and quarterly net income attributable to owners of the parent also exceeded the previous year.
  24. FY2019-Q3AdvancedAnnual report

    「Net sales for the cumulative first-quarter period under review increased by ¥139 million, or 1.2%, year on year, to ¥11,608 million. In terms of profit, the operating loss narrowed by ¥168 million year on year to ¥236 million, the ordinary loss narrowed by ¥86 million to ¥150 million, and the quarterly net loss attributable to owners of the parent narrowed by ¥21 million to ¥201 million.」

    In the first quarter under review, sales increased, while the operating loss, ordinary loss and quarterly net loss attributable to owners of the parent all narrowed from the previous year.
  25. FY2019-Q1First statedAnnual report

    「Net sales increased by ¥1,778 million, or 3.8%, year on year, to ¥48,280 million. In terms of profit, operating income increased by ¥496 million, or 14.3%, to ¥3,974 million, ordinary income increased by ¥299 million, or 8.3%, to ¥3,905 million, and quarterly net income attributable to owners of the parent increased by ¥231 million, or 10.7%, to ¥2,407 million, mainly due to higher net sales.」

    In the cumulative third-quarter period under review, net sales, operating income, ordinary income and quarterly net income attributable to owners of the parent all exceeded the same quarter of the previous year.
Moved together

"Promotion and Sales Expansion of Internally Developed Products and Expansion of Overseas Operations" moved the same way as this thread, in the same document, in 12 of its 25 moves.

121210777★123456
  1. ★This thread
  2. 1Promotion and Sales Expansion of Internally Developed Products and Expansion of Overseas Operations12×
  3. 2Weak Demand, Adverse Weather and Inventory Adjustments in Overseas Markets12×
  4. 3Impact of Shrinking Pesticide Demand and Intensifying Sales Competition10×
  5. 4Expanding the Product Portfolio Through New Product Launches7×
  6. 5Strengthening Drug Discovery Capabilities and Building a Global R&D Organization7×
  7. 6Expansion of Overseas Bases and Acceleration of Pesticide Registrations in Each Country7×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Nihon Nohyaku yet. It last moved in the Earnings of 2026-08-06: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.